Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
Anxiety disorders (obsessive-compulsive disorder, social phobia/selective mutism, panic disorder, separation anxiety, generalized anxiety disorder, simple phobia and post-traumatic stress disorder) are the most prevalent psychiatric disorders in children and adolescents. The selective serotonin reuptake inhibitors (SSRIs)--citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline--have demonstrated efficacy in treating anxiety disorders in adults. Although less information is available on the use of these agents in the paediatric population, research into the SSRIs for childhood anxiety disorders is increasing. This article reviews current literature, including case reports as well as open and controlled trials, on the effectiveness and tolerability of the SSRIs in the paediatric population. It also discusses developmental differences in children that should be considered in the utilisation of the SSRIs in paediatric patients.
Murphy
T K
TK
University of Florida, College of Medicine, Department of Psychiatry, Gainesville, USA. tmurphy@psych.ufl.edu
Bengtson
M A
MA
Tan
J Y
JY
Carbonell
E
E
Levin
G M
GM
D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D017367:Selective Serotonin Reuptake Inhibitors